Prospective evaluation of the first option, second-line Therapy in childhood chronic immune thrombocytopenia: splenectomy or immunomodulation

To describe four subgroups of pediatric patients treated with splenectomy, hydroxychloroquine, azathioprine or rituximab as the first-option, second-line treatment for chronic immune thrombocytopenia (cITP).

Source: The Journal of Pediatrics - December 16, 2020 Category: Pediatrics Authors: St éphane Ducassou, Helder Fernandes, Hélène Savel, Yves Bertrand, Thierry Leblanc, Wadih Abou Chahla, Marlène Pasquet, Guy Leverger, Vincent Barlogis, Caroline Thomas, Sophie Bayart, Isabelle Pellier, Corinne Armari-Alla, Corinne Guitton, Nathalie Ch Tags: Original Articles Source Type: research